PIP
ZBH icon

Palisades Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Palisades Investment Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$353K Sell
3,502
-2,575
-42% -$251K 0.63% 56
2014
Q1 		$558K Hold
6,077
– – 0.6% 59
2013
Q4 		$575K Sell
6,077
-9,888
-62% -$856K 0.64% 57
2013
Q3 		$1.27M Sell
15,965
-412
-3% -$32.4K 1.2% 36
2013
Q2 		$1.19M Buy
+16,377
New +$1.22M 1.18% 36

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Palisades Investment Partners's ZBH Position: Q2 2014 in Review

Palisades Investment Partners reduced its Zimmer Biomet (ZBH) stake by 42% in Q2 2014, selling an estimated $251K and leaving 3,502 shares worth $353K. The position accounts for 0.63% of the portfolio, ranked #56.

Palisades Investment Partners first reported a position in ZBH in Q2 2013 and has held it in 5 quarters since. The position peaked at $1.27M in Q3 2013. 707 funds tracked by Wall St. Rank hold ZBH as of Q2 2014.

  • Palisades Investment Partners held 3,502 shares of Zimmer Biomet worth $353K as of Q2 2014.
  • Palisades Investment Partners sold 2,575 Zimmer Biomet shares in Q2 2014, an estimated $251K.
  • Zimmer Biomet made up 0.63% of Palisades Investment Partners's portfolio in Q2 2014, its #56 holding.
  • Palisades Investment Partners first reported a position in Zimmer Biomet in Q2 2013 and has held it in 5 quarters since.
  • Palisades Investment Partners's Zimmer Biomet position peaked at $1.27M in Q3 2013.
  • 707 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2014.

Based on Palisades Investment Partners's 13F filing for Q2 2014, filed 28 Jul 2014.